ABA Chemicals Corporation (300261.SZ)
CNY 7.58
(0.13%)
CNY 7.58
(0.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -25.85 Million | 81.06 Million | 422.7 Million | 338.13 Million | 94.14 Million | 307.85 Million |
| Net Income | -72.36 Million | 219.53 Million | 195.51 Million | 172.57 Million | 104.61 Million | 184.42 Million |
| Depreciation & Amortization | 138.41 Million | 136.29 Million | 131.25 Million | 124.49 Million | 120.22 Million | 112.35 Million |
| Deferred income taxes | -30.71 Million | -2.88 Million | -1.97 Million | -12.93 Million | -12.87 Million | -7.78 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -153.36 Million | -340.24 Million | 64.11 Million | 18.87 Million | -184.92 Million | -29.92 Million |
| Other non-cash items | 22.8 Million | 65.48 Million | 31.82 Million | 22.19 Million | 54.22 Million | 40.99 Million |
| Investing Cash Flow | -233.87 Million | -230.93 Million | -58.01 Million | -145.97 Million | -84.43 Million | -740.59 Million |
| Investments in PPE | -232.27 Million | -189.95 Million | -91.22 Million | -93.9 Million | -103.15 Million | -311.13 Million |
| Acquisitions | -11.89 Million | 3.22 Million | 774.6 Thousand | 95.47 Million | -19.32 Million | -96.23 Million |
| Investment purchases | - | -80 Million | -157 Million | -350.1 Million | -295.6 Million | -1 Billion |
| Sales/Maturities of investments | 2.56 Million | 56.65 Million | 189.58 Million | 296.45 Million | 333.34 Million | 671.2 Million |
| Other Investing Activities | 10.28 Million | -20.86 Million | -149.99 Thousand | -93.9 Million | 293.88 Thousand | 603.82 Thousand |
| Financing Cash Flow | 127.44 Million | -33.25 Million | -324.18 Million | 14.93 Million | -95.85 Million | -81.48 Million |
| Debt repayment | -197.3 Million | -675.18 Million | -1.08 Billion | -839.79 Million | -947.11 Million | -832.83 Million |
| Dividends payments | -80.06 Million | -38.37 Million | -47.73 Million | -47.82 Million | -96.33 Million | -118.22 Million |
| Common Stock Repurchased | - | - | - | -34.98 Million | - | - |
| Common Stock Issuance | - | - | - | 34.98 Million | - | - |
| Other Financing Activities | 27.28 Million | 680.3 Million | 864.98 Million | 951.95 Million | 989.72 Million | 869.57 Million |
| Accounts receivables | 92.97 Million | -149.58 Million | 131.84 Million | 104.84 Million | -186.79 Million | -46.54 Million |
| Accounts payables | -113.67 Million | -56.09 Million | -60.09 Million | -4.98 Million | 39.99 Million | 38.3 Million |
| Inventory | -101.94 Million | -131.67 Million | -5.66 Million | -68.04 Million | -25.25 Million | -13.9 Million |
| Other working capital | 19.67 Million | -2.88 Million | -1.97 Million | -12.93 Million | -12.87 Million | -16.02 Million |
| Cash at beginning of period | 381.23 Million | 516.11 Million | 480.39 Million | 280.42 Million | 367.91 Million | 866.86 Million |
| Cash at end of period | 231.29 Million | 381.23 Million | 516.11 Million | 480.39 Million | 280.42 Million | 367.91 Million |
| Capital Expenditure | -232.27 Million | -189.95 Million | -91.22 Million | -93.9 Million | -103.15 Million | -311.13 Million |
| Effect of forex changes on cash | -17.64 Million | 48.23 Million | -4.77 Million | -7.13 Million | -1.34 Million | 15.28 Million |
| Net cash flow / Change in cash | -149.93 Million | -134.88 Million | 35.72 Million | 199.96 Million | -87.48 Million | -498.94 Million |
| Free Cash Flow | -258.13 Million | -108.88 Million | 331.47 Million | 244.23 Million | -9 Million | -3.28 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.7 Million | -6.43 Million | -45.57 Million | -72.36 Million | -156.22 Million | -20.08 Million |
| Depreciation & Amortization | - | 36 Million | 36 Million | 138.41 Million | 33.92 Million | -70.79 Million |
| Deferred income taxes | - | - | - | -30.71 Million | - | - |
| Stock-based compensation | - | 4.3 Million | - | - | - | - |
| Change in working capital | - | 36.78 Million | - | -153.36 Million | 10.7 Million | 81.69 Million |
| Other non-cash items | 24.34 Million | 107.97 Million | 51.91 Million | 22.8 Million | 156.22 Million | -3.28 Million |
| Investing Cash Flow | -27.8 Million | -26.52 Million | -34.73 Million | -233.87 Million | 21.95 Million | -131.29 Million |
| Investments in PPE | -28.13 Million | -26.7 Million | -34.73 Million | -232.27 Million | -59.52 Million | -45.57 Million |
| Acquisitions | 332.66 Thousand | 176.56 Thousand | 2 Million | -11.89 Million | 2.79 Million | 179.13 Thousand |
| Investment purchases | - | - | - | - | 150.32 Million | -150.32 Million |
| Sales/Maturities of investments | - | - | - | 2.56 Million | -63.76 Million | 64.42 Million |
| Other Investing Activities | 332.66 Thousand | 1.1 Million | - | 10.28 Million | -661.28 Thousand | 0.86 |
| Financing Cash Flow | -69.65 Million | -52.5 Million | 117.28 Million | 127.44 Million | 101.65 Million | 70.79 Million |
| Debt repayment | -59.02 Million | -31.03 Million | -104.39 Million | -197.3 Million | -86.4 Million | -245.9 Million |
| Dividends payments | -8.32 Million | -9.06 Million | -10.29 Million | -80.06 Million | -6.33 Million | -7.02 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.3 Million | -18.32 Million | 23.19 Million | 27.28 Million | 31.46 Million | 323.72 Million |
| Accounts receivables | - | -34.37 Million | - | 92.97 Million | 92.97 Million | 23.81 Million |
| Accounts payables | - | - | - | -113.67 Million | - | - |
| Inventory | - | 71.15 Million | - | -101.94 Million | -101.94 Million | 57.87 Million |
| Other working capital | - | - | - | 19.67 Million | 19.67 Million | - |
| Cash at beginning of period | 307.41 Million | 346.59 Million | 231.29 Million | 381.23 Million | 255.89 Million | 341.35 Million |
| Cash at end of period | 227.15 Million | 344.94 Million | 314.72 Million | 231.29 Million | 231.29 Million | 255.89 Million |
| Capital Expenditure | -28.13 Million | -26.7 Million | -34.73 Million | -232.27 Million | -59.52 Million | -45.57 Million |
| Effect of forex changes on cash | -2.44 Million | 6.19 Million | -5.46 Million | -17.64 Million | -30.52 Million | -11.6 Million |
| Net cash flow / Change in cash | -80.26 Million | -1.64 Million | 83.42 Million | -149.93 Million | -24.6 Million | -85.45 Million |
| Free Cash Flow | -8.49 Million | 38.83 Million | -28.39 Million | -258.13 Million | -177.44 Million | -58.04 Million |
BALTE
SCRH
KNYJY
605369
IFINSER
603648